INCYTE CORPORATION Deferred Income Tax Assets, Net
INCYTE CORPORATION (INCY) had Deferred Income Tax Assets, Net of $452.52 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-04-28
- 2026-03-31: Deferred Income Tax Assets, Net $452.52M.
- 2025-12-31: Deferred Income Tax Assets, Net $515.29M.
- 2025-09-30: Deferred Income Tax Assets, Net $528.14M.
- 2025-06-30: Deferred Income Tax Assets, Net $652.28M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-03-31 | $452.52M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $515.29M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $528.14M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $652.28M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $768.90M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $762.07M 10-K · filed 2026-02-10 |
| 2024-09-30 | $762.31M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $729.56M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $666.57M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $631.89M 10-K · filed 2025-02-10 |
| 2023-09-30 | $564.38M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $532.51M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $494.75M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $457.94M 10-K · filed 2024-02-13 |
| 2022-09-30 | $426.84M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $434.87M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $465.37M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $467.54M 10-K · filed 2023-02-07 |
| 2020-12-31 | $2.05M 10-K · filed 2022-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |